Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Vaccine    symbols : Sngx    save search

Global Vaccines Market Research Report 2022-2027: A $200+ Billion Industry - Forecasts, Company Market Share and Expert Market Estimates for Vaccine Categories
Published: 2023-02-08 (Crawled : 16:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 1.26% C: 0.99%
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.77% C: 0.19%
EBS | $2.04 9.68% 0.49% 930K twitter stocktwits trandingview |
Health Technology
| | O: -0.78% H: 0.79% C: -5.29%
SNGX | $0.4233 -2.76% -2.83% 1M twitter stocktwits trandingview |
Health Technology
| | O: -0.07% H: 4.9% C: 2.27%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 3.05% H: 0.0% C: 0.0%
NVAX | $3.99 2.57% 2.51% 2.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.74% C: -4.13%
INO 3 d | $9.68 -5.1% -5.37% 350K twitter stocktwits trandingview |
Health Technology
| | O: -1.61% H: 2.73% C: -8.47%
BNTX | $86.82 0.75% 0.75% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.35% H: 1.53% C: 0.68%

research global report vaccine market
Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine
Published: 2022-06-23 (Crawled : 12:00) - prnewswire.com
SNGX | $0.4233 -2.76% -2.83% 1M twitter stocktwits trandingview |
Health Technology
| | O: 3.58% H: 3.23% C: -2.9%

vaccine
Soligenix Receives US Patent Allowance for its Thermostabilized Vaccine Platform
Published: 2022-05-23 (Crawled : 12:00) - prnewswire.com
SNGX | $0.4233 -2.76% -2.83% 1M twitter stocktwits trandingview |
Health Technology
| | O: 2.02% H: 12.59% C: 6.2%

patent vaccine platform
Soligenix COVID-19 Vaccine, CiVax™, Boosts Neutralizing Activity against SARS-CoV-2, including Delta and Omicron
Published: 2022-03-17 (Crawled : 12:00) - prnewswire.com
SNGX | $0.4233 -2.76% -2.83% 1M twitter stocktwits trandingview |
Health Technology
| | O: 2.19% H: 3.14% C: 0.0%

covid-19 covid sars-cov-2 vaccine
Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine
Published: 2021-12-02 (Crawled : 13:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M twitter stocktwits trandingview |
Health Technology
| | O: -4.6% H: 1.22% C: -6.0%

vaccine
Soligenix Announces Publication Demonstrating Enduring Protection of its Thermostable RiVax® Vaccine
Published: 2021-11-04 (Crawled : 12:15) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M twitter stocktwits trandingview |
Health Technology
| | O: -0.98% H: 0.0% C: -0.99%

vaccine
Thermostable Vaccine Technology Platform to be Presented at the 6th International Conference on Vaccines Research and Development
Published: 2021-11-01 (Crawled : 13:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M twitter stocktwits trandingview |
Health Technology
| | O: -0.99% H: 1.0% C: 0.0%

vaccine technology research platform conference
Soligenix Announces Accelerated Publication Demonstrating Efficacy and Broad Neutralizing Activity of its COVID-19 Vaccine in Non-Human Primates
Published: 2021-09-28 (Crawled : 12:00) - prnewswire.com
SNGX | $0.4233 -2.76% -2.83% 1M twitter stocktwits trandingview |
Health Technology
| | O: -0.96% H: 6.8% C: 6.8%

covid vaccine
Soligenix Announces Publication Demonstrating Successful Formulation and Heat Stabilization of Filovirus Vaccine Platform for Ebola and Marburg Virus Diseases
Published: 2021-08-23 (Crawled : 12:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M twitter stocktwits trandingview |
Health Technology
| | O: 7.22% H: 1.4% C: 0.49%

disease vaccine marburg
Soligenix Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates
Published: 2021-08-18 (Crawled : 14:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M twitter stocktwits trandingview |
Health Technology
| | O: 15.94% H: 6.73% C: -7.79%

positive vaccine preclinical pre-clinical
Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development
Published: 2020-12-28 (Crawled : 13:07) - prnewswire.com
SNGX | $0.4233 -2.76% -2.83% 1M twitter stocktwits trandingview |
Health Technology
| | O: 3.73% H: 0.72% C: -5.04%

covid vaccine research covid-19 awards
Soligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine
Published: 2020-12-08 (Crawled : 16:01) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M twitter stocktwits trandingview |
Health Technology
| | O: 5.08% H: 0.0% C: -6.85%

vaccine
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.